Vimarsana
Biggest News Aggregation in the World

Small Pharma Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Pharma Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Pharma Ltd Today - Breaking & Trending Today

Cybin : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K -September 14, 2023 at 03:02 pm EDT - Vimarsana News

Cybin : NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR - Form 6-K -September 14, 2023 at 03:02 pm EDT

NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS AND MANAGEMENT INFORMATION CIRCULAR ...

Small Pharma (CVE:DMT) Reaches New 1-Year Low at $0.21 - Vimarsana News

Small Pharma (CVE:DMT) Reaches New 1-Year Low at $0.21

Small Pharma Inc. (CVE:DMT – Get Rating)’s stock price hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as C$0.21 and last traded at C$0.21, with a volume of 79732 shares. The stock had previously closed at C$0.22. Separately, Eight Capital set a C$1.00 price objective on Small […]

Small Pharma (CVE:DMT) Reaches New 52-Week Low at $0.21 - Vimarsana News

Small Pharma (CVE:DMT) Reaches New 52-Week Low at $0.21

Small Pharma Inc. (CVE:DMT – Get Rating)’s stock price reached a new 52-week low on Monday . The company traded as low as C$0.21 and last traded at C$0.21, with a volume of 203932 shares traded. The stock had previously closed at C$0.24. Separately, Eight Capital set a C$1.00 price objective on shares of Small […]

Small Pharma (CVE:DMT) Reaches New 1-Year Low at $0.21 - Vimarsana News

Small Pharma (CVE:DMT) Reaches New 1-Year Low at $0.21

Small Pharma Inc. (CVE:DMT – Get Rating) reached a new 52-week low during trading on Monday . The stock traded as low as C$0.21 and last traded at C$0.21, with a volume of 203932 shares changing hands. The stock had previously closed at C$0.24. Separately, Eight Capital set a C$1.00 price target on shares of […]

Small Pharma to Restate Financial Statements to Reflect IFRS Fair Value of Convertible Notes and Share Options - Vimarsana News

Small Pharma to Restate Financial Statements to Reflect IFRS Fair Value of Convertible Notes and Share Options

19.10.2021 - The restatements relate to non-cash items with no material impact to the Company’s ongoing operations or cash positionLONDON, Oct. 18, 2021 (GLOBE NEWSWIRE) - Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical ... Seite 1